After finishing at $1.22 in the prior trading day, OptiNose Inc (NASDAQ: OPTN) closed at $1.19, down -2.46%. On the day, 508555 shares were traded.
Ratios:
Our goal is to gain a better understanding of OPTN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.55 and its Current Ratio is at 0.60.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on March 11, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On August 21, 2023, Lake Street started tracking the stock assigning a Buy rating and target price of $3.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 18 ’24 when Mahmoud Ramy A sold 19,198 shares for $1.88 per share. The transaction valued at 36,092 led to the insider holds 1,331,278 shares of the business.
Marino Michael F III sold 15,059 shares of OPTN for $28,311 on Mar 18 ’24. The Chief Legal Officer & Corp Sec now owns 602,268 shares after completing the transaction at $1.88 per share. On Mar 18 ’24, another insider, Krick Anthony J, who serves as the Chief Accounting Officer of the company, sold 2,345 shares for $1.88 each. As a result, the insider received 4,409 and left with 143,988 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.89.
Stock Price History:
Over the past 52 weeks, OPTN has reached a high of $2.10, while it has fallen to a 52-week low of $0.90.
Shares Statistics:
A total of 112.40M shares are outstanding, with a floating share count of 80.41M. Insiders hold about 28.62% of the company’s shares, while institutions hold 56.98% stake in the company.
Earnings Estimates
Its stock is currently analyzed by Opendoor Technologies Inc different market analysts. The consensus estimate for the next quarter is $1.82, with high estimates of $19.08 and low estimates of $0.66.
Analysts are recommending an EPS of between $Consumer Defensive and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.
